Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
Parabilis Medicines, Inc.
Ruijin Hospital
Eli Lilly and Company
Dana-Farber Cancer Institute
Fudan University
I-Mab Biopharma US Limited
University Hospital, Akershus
Duke University
AstraZeneca
City of Hope Medical Center
UNICANCER
NuCana plc
Memorial Sloan Kettering Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
NuCana plc
Federation Francophone de Cancerologie Digestive
M.D. Anderson Cancer Center
Gruppo Oncologico del Nord-Ovest
IGM Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Immodulon Therapeutics Ltd
Federation Francophone de Cancerologie Digestive
OHSU Knight Cancer Institute
University of Cologne
Hoosier Cancer Research Network
National Institutes of Health Clinical Center (CC)
National Cancer Institute, Naples
Federation Francophone de Cancerologie Digestive
Brown University
EMD Serono
GSO Global Clinical Research BV
UNICANCER
Translational Oncology Research International
Grupo Espanol Multidisciplinario del Cancer Digestivo
Grupo Espanol Multidisciplinario del Cancer Digestivo
AIO-Studien-gGmbH
UNICANCER
UNICANCER
University of Florida
American College of Radiology Imaging Network
AstraZeneca
Massachusetts General Hospital
Daiichi Sankyo
Eli Lilly and Company
Abramson Cancer Center at Penn Medicine
Epidemiological and Clinical Research Information Network
Amgen
Georgetown University